Effects of B-Cell depleting therapy (Rituximab) on liver biochemistry in UDCA-responsive patients: results from a randomised controlled trial of Rituximab in fatigued PBC patients (RitPBC).
HEPATOLOGY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined